Department of General Surgery (Division of Visceral Surgery)
Position: Associate Professor
ORCID: 0000-0002-3068-5050
T +43 1 06607267174
klaus.sahora@meduniwien.ac.at
Keywords
Carcinoma, Pancreatic Ductal; Exocrine Pancreatic Insufficiency; Pancreas; Pancreatectomy; Pancreatic Cyst; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis
Research group(s)
- Pancreatic surgery
Head: Martin Schindl
Research Area: Body composition and inflammation in pancreatic neoplasms.
Members: - Pancreatic Cancer Unit
Research Area: Diagnostic and treatment of pancreatic cancer and pancreatitis Intraductal papillary mucinous neoplasms Prehabilitation program before surgery
Members:
Research interests
My main research focus is to understand the importance of pancreatic cancer and neoplasic cystic lesions of the pancreas (ie. Intraductal papillary mucinous neoplasm IPMN; mucinous cystic neoplasm MCN) The research is designed to elucidate mechanisms underlying the different typs of pancreas cysts and to develop novel surgical approaches inpancreatic cancer surgery.
Selected publications
- Sahora, K. et al. (2013) ‘Branch Duct Intraductal Papillary Mucinous Neoplasms’, Annals of Surgery, 258(3), pp. 466–475. Available at: http://dx.doi.org/10.1097/sla.0b013e3182a18f48.
- Sahora, K. et al. (2014) ‘Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: Implications of minimal involvement of the main pancreatic duct’, Surgery, 156(3), pp. 611–621. Available at: http://dx.doi.org/10.1016/j.surg.2014.04.023.
- Sahora, K. et al. (2015) ‘Effects of Comorbidities on Outcomes of Patients With Intraductal Papillary Mucinous Neoplasms’, Clinical Gastroenterology and Hepatology, 13(10), pp. 1816–1823. Available at: http://dx.doi.org/10.1016/j.cgh.2015.04.177.
- Sahora, K. et al. (2011) ‘NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer’, Surgery, 149(3), pp. 311–320. Available at: http://dx.doi.org/10.1016/j.surg.2010.07.048.
- Gruber, E.S. et al. (2019) ‘Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma’, PLOS ONE. Edited by F.X. Real, 14(5), p. e0215915. Available at: http://dx.doi.org/10.1371/journal.pone.0215915.